Global Glycomics/Glycobiology Market Size, Share, Forecast Report, 2020-2027

The global glycomics/glycobiology market is growing significantly, at a CAGR of around 13.5% during the forecast period (2019-2025). Glycomics refers to the structural and functional analysis of glycomes present in biological systems and also identify genes that encode glycoproteins. There are various pivotal factors that are driving the global glycomics market, which includes the increasing focus on proteomics and glycomics research processes and rising demand for personalized medicines. For instance, there are more than 100 research laboratories present in nearly 76 research or academic institutes in India that are insistently involved in the investigation of proteome-level researches. Various research groups from India are involved in high quality research on proteomics of various infectious diseases and human cancers, which in turn, is offering growth to the global glycomics market.



In addition, the technological advancements in the glycomics instruments are further propelling the growth of the global glycomics market. Methods such as enrichment, derivatization of glycopeptides, and metabolic labeling in conjunction with several mass spectrometry techniques and bioinformatics tools, have been recently developed to achieve an unequivocal qualitative and quantitative characterization of glycoproteins. Funding for R&D in glycomics and biomarker identification are driving the global market growth. Despite these growth factors, there are certain factors that hampers the market growth, including high cost of instruments and stringent government policies and regulations.



Segmental Outlook



The glycomics market is classified on the basis of product type, application, and end-user. Based on product type, the market is segregated into reagents and kits, instruments, enzymes, and carbohydrates. Based on application, the market is segmented into drug discovery and disease diagnostics. Based on end-user, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, and hospitals and clinics.



Global glycomics market to be driven by the significant use of instruments in glycomic study



Instruments are considered as one of the major product involved in the study of glycomics. There are a range of instruments used in the research process, including mass spectrometry instruments, chromatography instruments, and arrays, among others. These instruments play a major role in the characterization of glycans during drug discovery and diagnosis of disease. Among these instruments, the mass spectrometry instrument contributes the major share in the growth of the instruments segment in the glycomics market. Mass spectrometry instrument is used to identify small amount of glycans from a complex mixture. With its increasing applications, the market players are engaged in the development of novel and efficient mass spectrometers. In June 2018, Thermo Fisher Scientific Inc. launched ultra-high mass range mass spectrometer, which will offer better understanding of protein structure and interactions.



Regional Outlook



The global glycomics market is classified on the basis of geography, which includes North America, Europe, Asia-Pacific, and Rest of the World. North America is estimated to contribute significant share in the global glycomics market. The major countries which play a role in the North American market growth include the US and Canada. The well-developed healthcare infrastructure and significant government healthcare spending is promoting R&D of personalized medicine across the region; thereby, promoting the growth of the market. Stowers Institute for Medical Research in the US offers a multidimensional protein identification technology (MudPIT) which is based on a chromatography-based proteomic approach. MudPIT allows the discovery and identification of low abundance proteins and is extremely sensitive. In addition, the presence of key market players, such as Thermo Fisher Scientific Inc. and Agilent Technologies, Inc., is another major factor that drives the market growth in the region.



Asia-Pacific is expected to propel with a considerable growth rate in the global market



Asia-Pacific is expected to project a considerable growth in the global glycomics market. This growth can be attributed to the growing healthcare infrastructure and investments by CROs for the production and development of drugs. In addition, the huge population base is significantly gaining the traction from pharmaceutical and biotechnology companies, with which these companies are expanding their presence in emerging economies of Asia-Pacific, especially in India and China. Growth in these countries is also attributed to the increasing collaboration amongst pharmaceutical companies and research institutes for the drug development. For instance, in December 2019, Institute of Glycomics of Griffith University signed a partnership agreement with Grand Medical Ltd. for the development of novel drugs for Human Parainfluenza Virus.



Market Players Outlook



The key players in the glycomics market are contributing significantly by providing advanced technology-based products and through expanding their geographical presence across the globe. The key players operating in the global glycomics market include Merck KGaA, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Takara Bio Inc., and New England Biolabs, Inc. These market players adopt various strategies such as product launch, partnerships, collaborations, merger, and acquisitions to sustain a strong position in the market.